CD4 and neoplasm: Increased activity of the KLRB1 gene has been described in many human cancers, overexpression of CD161 was found on CD4+ effector T cells and on CD8+ T cells but not on T regulatory cells, and experimental inactivation of the KLRB1 gene confirmed the enhancement of the antitumor activity of tumor-invading T cells [22].